Carlos Diéguez González-rekin lankidetzan egindako argitalpenak (7)

1986

  1. GROWTH HORMONE RESPONSES TO GRF 1–29 IN PATIENTS WITH PRIMARY HYPOTHYROIDISM BEFORE AND DURING REPLACEMENT THERAPY WITH THYROXINE

    Clinical Endocrinology, Vol. 24, Núm. 6, pp. 693-698

  2. Growth hormone responses to growth hormone-releasing factor (1-29) in euthyroid, hypothyroid and hyperthyroid rats

    Journal of Endocrinology, Vol. 109, Núm. 1, pp. 53-56

  3. INFLUENCE OF DOPAMINERGIC, ADRENERGIC AND CHOLINERGIC BLOCKADE AND TRH ADMINISTRATION ON GH RESPONSES TO GRF 1–29

    Clinical Endocrinology, Vol. 24, Núm. 3, pp. 291-298

  4. LACK OF EFFECT OF MUSCARINIC CHOLINERGIC BLOCKADE ON THE GH RESPONSES TO GRF 1–29 AND TRH IN ACROMEGALIC SUBJECTS

    Clinical Endocrinology, Vol. 24, Núm. 4, pp. 415-420

1985

  1. Differential effects of acute DA receptor blockade with domperidone on LH and TSH release in patients with hyperprolactinemia

    Journal of Endocrinological Investigation: Official Journal of the Italian Society of Endocrinology, Vol. 8, Núm. 2, pp. 163-166

1983

  1. Exaggerated circadian variation in basal thyrotropin (tsh) and in the dopaminergic inhibition of tsh release in pathological hyperprolactinemia: Evidence against a hypothalamic dopaminergic defect

    Journal of Clinical Endocrinology and Metabolism, Vol. 57, Núm. 5, pp. 975-980

  2. Problemática actual en el diagnóstico diferencial de la hiperprolactinemia.

    Revista de medicina de la Universidad de Navarra, Vol. 27, Núm. 3, pp. 11-18